Mitsubishi Pharma Corp
Pacific Therapeutics, Inc
University of Texas – Austin
University of Washington
|Sung Wan Kim
University of Utah
Boston Children's Hospital
Professor, Osaka University
Self-organizing nano-biomaterials: Nano-particles and nano-films
Chief Executive Officer, BIND Biosciences, Inc.
Targeted nanoparticles for therapeutic applications
Vice President, Medical Affairs, Director, Generex Biotechnology Corp
Buccal delivery of drugs for diabetes
Professor, Johns Hopkins School of Medicine
Advances in brain tumor therapy
Director of Pharmaceutics and Drug Delivery, Amgen
Delivery enhanced biopharmaceuticals: Overcoming barriers to commercialization
Chief Technology Officer, WMR Biomedical, Inc
President and CTO, Corium International, Inc.
Associate Professor, Kyoto University
Bone marrow stromal cells fro auto-cell transplantation therapy: Applications for neuro- and muscle-degenerative diseases
Colin R. Gardner
Chief Scientific Officer, TransForm Pharmaceuticals, Inc.
Materials Science impact on drug formulation
Professor, Hokkaido University
In vivo siRNA delivery with MEND
Mitsuru Hashida Yuriko Higuchi
Professor, Kyoto University Professor, Kyoto University
Development of ligand modified quantum dots for imaging
Vice President, Research & Development & Chief Scientific Officer, Calando Pharmaceuticals
Targeted siRNA-containing formulations for clinical, systemic application
Professor, Kyoto University
A strategy for treatment of inner ear diseases using new drug delivery system
Professor, Osaka University
Development of virosome-based drug delivery systems for cancer therapy
Professor, Rutgers University
Combinatorial discovery approaches accelerate the development of drug eluting combination devices
Vice President of Research, Alnylam Pharmaceuticals
Achieving therapeutic silencing by RNAi: Progress and perspectives
Min Young Lee
Vice President, Sam Yang Corporation
Launch of Genexol-PM with bio-polymers increasing therapeutic index (tentative)
Senior Manager, Astellas Pharma, Inc.
Study on enzymatic cleavable polymer coated long-circulating liposome system
Chief, Investigative Treatment Division, National Cancer Center Hospital East
Micelle carrier system in cancer chemotherapy
Vice President Polymer Chemistry, Genzyme Drug & Biomaterial R & D
Properties of Chemically Modified Hyaluronan and Other Macromolecules
Professor, Keio University School of Medicine
Novel therapeutic strategies for CNS-repair
Founder and CSO, Nektar Therapeutics
New pulmonary and pegylation advances
VP., Commercial Strategy, Gilead Sciences, Inc.
What’s new in cystic fibrosis therapy
Senior Manager, Dainippon Sumitomo Pharma Co., Ltd.
Atelocollagen-mediated technology as an effective drug delivery system for nucleic drugs
President & CEO, MicroCHIPS, Inc.
Programmable drug delivery from implantable multi-reservoir devices
MIT Biological Engineering & Center for Cancer Research
Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system
Chief Scientific Officer, Insert Therapeutics, Inc.
Cyclodextrin polymer nanoparticles for cancer therapy: New molecules and first clinical results
Chairman and CEO, Cydex, Inc.
Unique Pharmaceutical solubilization examples; Unique product differentiation
Chief Executive Officer, Avidimer Therapeutics
Dendrimers as nanomolecular platforms for targeted therapeutics
Ono Pharmaceutical Co., Ltd.
A new platform for gastric retentive system as a sustained release formulation
Professor, University of California, San Francisco
New molecules for lipid based drug delivery
[Back to Top]